Antibody response against heterogeneous circulating influenza virus strains elicited by MF59-and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates

被引:84
作者
Ansaldi, Filippo [1 ]
Zancolli, Marta [1 ]
Durando, Paolo [1 ]
Montomoli, Emanuele [2 ]
Sticchi, Laura [1 ]
Del Giudice, Giuseppe [3 ]
Icardi, Giancarlo [1 ]
机构
[1] Univ Genoa, Dept Hlth Sci, CIRI IV, I-16100 Genoa, Italy
[2] Univ Siena, Dept Physiopathol Expt Med & Publ Hlth, I-53100 Siena, Italy
[3] Novartis Vaccines, Siena, Italy
关键词
Influenza; MF59; Cross-protection;
D O I
10.1016/j.vaccine.2010.04.030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MF59 is already known to enhance the breadth of antibody response to mismatched influenza seasonal and avian strains. However, little is known on the effect of MF59 on immunogenicity of influenza vaccines when "apparent" good matching between circulating and vaccine strains exists. To this end, we compared the immune response elicited by MF59-adjuvanted or non-adjuvanted subunit vaccine, containing A/California/7/04(H3N2) strain, against circulating viruses isolated between 2004/2005 and 2006/2007 seasons, belonging to different clades. The advantage offered by MF59 in terms of higher immunogenicity, expressed as higher post-vaccination HI titres, is observable also against viruses showing antigenic and molecular pattern undistinguishable from vaccine strain, but it became even more evident as the antigenic and molecular distance between vaccine and circulating strains grew. These data show that seasonal influenza vaccine adjuvanted with MF59 can offer a stronger benefit as compared to non-adjuvanted vaccine in protecting against a broader range of virus strains circulating during the influenza season. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4123 / 4129
页数:7
相关论文
共 20 条
  • [1] Antigenic characterisation of influenza B virus with a new microneutralisation assay: Comparison to haemagglutination and sequence analysis
    Ansaldi, F
    Bacilieri, S
    Amicizia, D
    Valle, L
    Banfi, F
    Durando, P
    Sticchi, L
    Gasparini, R
    Icardi, G
    Crovari, P
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2004, 74 (01) : 141 - 146
  • [2] Cross-protection by MF59™-adjuvanted influenza vaccine:: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
    Ansaldi, Filippo
    Bacilieri, Sabrina
    Durando, Paolo
    Sticchi, Laura
    Valle, Laura
    Montomoli, Ernanuele
    Icardi, Giancarlo
    Gasparini, Roberto
    Crovari, Pietro
    [J]. VACCINE, 2008, 26 (12) : 1525 - 1529
  • [3] Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases
    Baldo, V.
    Baldovin, T.
    Floreani, A.
    Fragapane, E.
    Trivello, R.
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2007, 27 (05) : 542 - 547
  • [4] Seroprotection rate, mean fold increase, seroconversion rate:: which parameter adequately expresses seroresponse to influenza vaccination?
    Beyer, WEP
    Palache, AM
    Lüchters, G
    Nauta, J
    Osterhaus, ADME
    [J]. VIRUS RESEARCH, 2004, 103 (1-2) : 125 - 132
  • [5] Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages
    Camilloni, B.
    Neri, M.
    Lepri, E.
    Iorio, A. M.
    [J]. VACCINE, 2009, 27 (31) : 4099 - 4103
  • [6] An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine
    Del Giudice, G
    Hilbert, AK
    Bugarini, R
    Minutello, A
    Popova, O
    Toneatto, D
    Schoendorf, I
    Borkowski, A
    Rappuoli, R
    Podda, A
    [J]. VACCINE, 2006, 24 (16) : 3063 - 3065
  • [7] Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
    Galli, Grazia
    Medini, Duccio
    Borgogni, Erica
    Zedda, Luisanna
    Bardelli, Monia
    Malzone, Carmine
    Nuti, Sandra
    Tavarini, Simona
    Sammicheli, Chiara
    Hilbert, Anne K.
    Brauer, Volker
    Banzhoff, Angelika
    Rappuoli, Rino
    Del Giudice, Giuseppe
    Castellino, Flora
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) : 3877 - 3882
  • [8] Quantifying influenza vaccine efficacy and antigenic distance
    Gupta, Vishal
    Earl, David J.
    Deem, Michael W.
    [J]. VACCINE, 2006, 24 (18) : 3881 - 3888
  • [9] HAY AJ, 2005, CHARACTERISTICS HUMA
  • [10] HAY AJ, 2003, CHARACTERISTICS HUMA